EFFECT OF PROBUCOL, PANTETHINE AND THEIR COMBINATIONS ON SERUM-LIPOPROTEIN METABOLISM AND ON THE INCIDENCE OF ATHEROMATOUS LESIONS IN THE RABBIT

被引:37
作者
TAWARA, K
ISHIHARA, M
OGAWA, H
TOMIKAWA, M
机构
关键词
D O I
10.1254/jjp.41.211
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:211 / 222
页数:12
相关论文
共 32 条
[1]  
[Anonymous], 1978, J Chronic Dis, V31, P201
[2]  
BARNHART JW, 1970, AM J CLIN NUTR, V23, P1229
[3]   OVERVIEW OF BIOCHEMICAL PHARMACOLOGY OF PROBUCOL [J].
BARNHART, JW ;
RYTTER, DJ ;
MOLELLO, JA .
LIPIDS, 1977, 12 (01) :29-33
[4]   PANTETHINE REDUCES PLASMA-CHOLESTEROL AND THE SEVERITY OF ARTERIAL LESIONS IN EXPERIMENTAL HYPERCHOLESTEROLEMIC RABBITS [J].
CARRARA, P ;
MATTURRI, L ;
GALBUSSERA, M ;
LOVATI, MR ;
FRANCESCHINI, G ;
SIRTORI, CR .
ATHEROSCLEROSIS, 1984, 53 (03) :255-264
[6]   HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].
GORDON, T ;
CASTELLI, WP ;
HJORTLAND, MC ;
KANNEL, WB ;
DAWBER, TR .
AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714
[7]   THE EFFECT OF PROBUCOL AND CHOLESTYRAMINE COMBINATION THERAPY IN SEVERE FAMILIAL HYPERCHOLESTEROLEMIA [J].
JACKSON, JM ;
LEE, HA .
ATHEROSCLEROSIS, 1984, 51 (2-3) :189-197
[8]   CHOLESTEROL IN THE PREDICTION OF ATHEROSCLEROTIC DISEASE - NEW PERSPECTIVES BASED ON THE FRAMINGHAM STUDY [J].
KANNEL, WB ;
CASTELLI, WP ;
GORDON, T .
ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :85-91
[9]   PROBABILITY OF MIDDLE-AGED MEN DEVELOPING CORONARY HEART-DISEASE IN 5 YEARS [J].
KEYS, A ;
KARVONEN, MJ ;
BLACKBURN, H ;
ARAVANIS, C ;
BUZINA, R ;
MENOTTI, A ;
FIDANZA, F ;
TAYLOR, HL ;
VANBUCHE.FS ;
PUDDU, V ;
DJORDJEVIC, BS .
CIRCULATION, 1972, 45 (04) :815-+
[10]  
KRITCHEVSKY D, 1970, P SOC EXP BIOL MED, V136, P1216